DALLAS, TX--(Marketwire - December 05, 2011) - Metiscan, Inc. (PINKSHEETS: MTIZ) announced today that Metiscan's President, CEO and Acting CFO has released a letter to shareholders discussing Metiscan's name change, reverse split, status and the Company's goals and expectations for 2011. The letter discusses topics of interest to shareholders including the details of Metiscan's name change and reverse split, the status of its registration statement filed on Form 10, a review of its 3rd quarter financials and its goals for 2012.

"This summer, Metiscan went through a Metamorphosis," commented Curtis Gung, Metiscan's President, CEO and Acting CFO. "Metiscan divested all of its operating subsidiaries, replaced its management team and acquired Aclor, Inc. and its wholly-owned subsidiary Aclor Servicios Administrativos, S. de R.L. This event marked Metiscan's entry into the consumer and office paper converter industry and its renewed commitment to its shareholders."

Mr. Gung continued, "We have a vision of an internationally recognized brand trading on a respected public market. This vision includes organic growth and growth through acquisition of like companies. We believe we have the resources to reach our vision. Today we are laying the foundation for our future success. We believe that Metiscan is an attractive long-term investment and are hopeful that our stockholders agree."

Metiscan, Inc. is a public holding company traded on the Pink Sheets under the symbol MTIZ. Its sole, wholly-owned subsidiary Aclor, Inc. is an international manufacturer and supplier of private label paper products. Aclor's customers include some of the most recognized and reputable office supply mass retailers worldwide and also include the largest consumer and office retailer in the United States. Aclor produces composition notebooks, spiral notebooks, wireless notebooks, and filler paper in its factory located in Nuevo Laredo, Tamaulipas, Mexico.

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan's actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "intends," "anticipates" or "plans" to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.